Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27165039 | 1.00 | CA1 (0.53) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL27204437 | 1.00 | CA1 (0.53) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL6979683 | 1.00 | CA1 (0.53) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL27204438 | 1.00 | CA1 (0.53) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL813507 | 1.00 | CA1 (0.53) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL30735725 | 0.96 | CA1 (0.48) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL10491745 | 0.86 | CA1 (0.43) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL10491666 | 0.86 | MAPT (0.49) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL10491694 | 0.86 | MAPT (0.49) | CA1ALDH1A1KDM4EHPGDNPC1 | |
| SCHEMBL13254555 | 0.86 | ALDH1A1 (0.46) | CA1ALDH1A1KDM4EHPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284761-A | Preparation and application of chiral cyclohexanediamine supported polyisonitrile catalyst | 北方民族大学 | 2023-06-23 | — | — | CN | disclosed |
| US-9006303-B2 | Mesoporous polymer colloids | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-04-14 | — | — | US | disclosed |
| US-8399684-B2 | Sulfonamide-based organocatalysts and method for their use | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2013-03-19 | — | — | US | disclosed |
| US-8399684-B2 | Sulfonamide-based organocatalysts and method for their use | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2013-03-19 | — | — | US | disclosed |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | UNIVERSITE DE MONTREAL (CA) | 2012-09-13 | — | — | US | disclosed |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | UNIVERSITE DE MONTREAL (CA) | 2012-09-13 | — | — | US | disclosed |
| EP-2366700-A1 | Pyrrolidine-thioxopyrimidinone/thiohydantoin organocatolysts | National and Kapodistrian Universty of Athens (GR) | 2011-09-21 | — | — | EP | disclosed |
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | PHOSTECH LITHIUM INC. (CA) | 2011-07-21 | — | — | US | disclosed |
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | PHOSTECH LITHIUM INC. (CA) | 2011-07-21 | — | — | US | disclosed |
| US-7968734-B2 | Organocatalysts and methods of use in chemical synthesis | STC.UNM (US) | 2011-06-28 | — | — | US | disclosed |
| US-7968734-B2 | Organocatalysts and methods of use in chemical synthesis | STC.UNM (US) | 2011-06-28 | — | — | US | disclosed |
| US-7968734-B2 | Organocatalysts and methods of use in chemical synthesis | STC.UNM (US) | 2011-06-28 | — | — | US | disclosed |
| US-7919629-B2 | Sulphonyl-1,2,4-triazole salts | PHOSTECH LITHIUM INC. (CA) | 2011-04-05 | — | — | US | disclosed |
| US-20100210744-A1 | Mesoporous Polymer Colloids | SINGAPORE AGENCY FOR SCIENCE, TECHNOLOGY AND RESEA (SG) | 2010-08-19 | — | — | US | disclosed |
| US-20100184986-A1 | SULFONAMIDE-BASED ORGANOCATALYSTS AND METHOD FOR THEIR USE | The State of Oregon acting by and through the State Board of Higher Education on behalf of Orego | 2010-07-22 | — | — | US | disclosed |
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | PHOSTECH LITHIUM INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | STC.UNM (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | STC.UNM (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | STC.UNM (US) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | TST, STS, SQOR | CA1 365/4885ALDH1A1 1639/4885KDM4E 1915/4885 |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | SCO2, CBR1, CBR3 | CA1 152/4885ALDH1A1 1287/4885KDM4E 3845/4885 |
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | TST, STS, SQOR | CA1 365/4885ALDH1A1 1639/4885KDM4E 1915/4885 |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | STS, TST, FIS1 | CA1 506/4885ALDH1A1 1554/4885KDM4E 2085/4885 |
| US-20100184986-A1 | SULFONAMIDE-BASED ORGANOCATALYSTS AND METHOD FOR THEIR USE | ALDH7A1, SULT1A1, SULT2A1 | CA1 1253/4885ALDH1A1 12/4885KDM4E 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.